Download PDF
Digestive Disease Interventions 2017; 01(04): 286-292
DOI: 10.1055/s-0037-1620280
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA

Balloon-Occluded Retrograde Transvenous Obliteration: Emergence as a Treatment for Gastric Varices and Medically Refractory Hepatic Encephalopathy

Ronnie C. Chen
1   Division of Interventional Radiology, Department of Radiology, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, California
,
Edward Wolfgang Lee
1   Division of Interventional Radiology, Department of Radiology, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, California
,
Sung Ki Cho
2   Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
› Author Affiliations
Further Information

Publication History

04 December 2017

07 December 2017

Publication Date:
19 January 2018 (online)

Also available at
    Permissions and Reprints

Abstract

Gastric or esophageal variceal bleeding is a major complication of portal hypertension in patients with liver cirrhosis. Currently, liver transplant is still considered a gold standard treatment for gastric or esophageal variceal bleeding. What about varices associated with splenic vein thrombosis? In the United States and Europe, endoscopic treatment and transjugular intrahepatic portosystemic shunt (TIPS) have been considered as effective treatment options for these variceal bleeding. However, in South Korea and Japan, balloon-occluded retrograde transvenous obliteration (BRTO) has been considered as a well-accepted treatment option for the gastric variceal bleeding. In recent years, based on favorable outcomes of BRTO in Asia and unfavorable outcomes/complications of TIPS, BRTO has emerged as an alternative therapy for gastric varices in the Western world. In this review, we describe the indications/contraindications, techniques, and outcomes of BRTO.

Keywords

BRTO - gastric variceal bleeding - TIPS - hepatic encephalopathy
 

  • References

  • 1 Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology 1988; 95 (02) 434-440
    CrossrefPubMedGoogle Scholar
  • 2 Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology 2004; 126 (04) 1175-1189
    CrossrefPubMedGoogle Scholar
  • 3 Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017; 65 (01) 310-335
    CrossrefPubMedGoogle Scholar
  • 4 Tripathi D, Therapondos G, Jackson E, Redhead DN, Hayes PC. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002; 51 (02) 270-274
    CrossrefPubMedGoogle Scholar
  • 5 Olson E, Yune HY, Klatte EC. Transrenal-vein reflux ethanol sclerosis of gastroesophageal varices. AJR Am J Roentgenol 1984; 143 (03) 627-628
    CrossrefPubMedGoogle Scholar
  • 6 Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996; 11 (01) 51-58
    CrossrefPubMedGoogle Scholar
  • 7 Cho SK, Shin SW, Lee IH. , et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. AJR Am J Roentgenol 2007; 189 (06) W365-72
    PubMedGoogle Scholar
  • 8 Choi SY, Won JY, Kim KA, Lee DY, Lee KH. Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO). Eur Radiol 2011; 21 (01) 122-129
    CrossrefPubMedGoogle Scholar
  • 9 Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001; 12 (03) 327-336
    CrossrefPubMedGoogle Scholar
  • 10 Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features. Radiographics 2003; 23 (04) 921-937 , discussion 937
    CrossrefPubMedGoogle Scholar
  • 11 Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices. Part 1. Anatomic classification. Radiographics 2003; 23 (04) 911-920
    CrossrefPubMedGoogle Scholar
  • 12 Koito K, Namieno T, Nagakawa T, Morita K. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. AJR Am J Roentgenol 1996; 167 (05) 1317-1320
    CrossrefPubMedGoogle Scholar
  • 13 Park SJ, Chung JW, Kim HC, Jae HJ, Park JH. The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices. J Vasc Interv Radiol 2010; 21 (04) 503-507
    CrossrefPubMedGoogle Scholar
  • 14 Sonomura T, Ono W, Sato M. , et al. Emergency balloon-occluded retrograde transvenous obliteration of ruptured gastric varices. World J Gastroenterol 2013; 19 (31) 5125-5130
    CrossrefPubMedGoogle Scholar
  • 15 Takuma Y, Nouso K, Makino Y, Saito S, Shiratori Y. Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis. Clin Gastroenterol Hepatol 2005; 3 (12) 1245-1252
    CrossrefPubMedGoogle Scholar
  • 16 Ferral H, Gamboa P, Postoak DW. , et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology 2004; 231 (01) 231-236
    CrossrefPubMedGoogle Scholar
  • 17 Ferral H, Patel NH. Selection criteria for patients undergoing transjugular intrahepatic portosystemic shunt procedures: current status. J Vasc Interv Radiol 2005; 16 (04) 449-455
    CrossrefPubMedGoogle Scholar
  • 18 Saad WE, Kitanosono T, Koizumi J, Hirota S. The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications. Tech Vasc Interv Radiol 2013; 16 (02) 101-151
    CrossrefPubMedGoogle Scholar
  • 19 Imai Y, Nakazawa M, Ando S, Sugawara K, Mochida S. Long-term outcome of 154 patients receiving balloon-occluded retrograde transvenous obliteration for gastric fundal varices. J Gastroenterol Hepatol 2016; 31 (11) 1844-1850
    CrossrefPubMedGoogle Scholar
  • 20 Saad WE, Simon Jr PO, Rose SC. Balloon-occluded retrograde transvenous obliteration of gastric varices. Cardiovasc Intervent Radiol 2014; 37 (02) 299-315
    CrossrefPubMedGoogle Scholar
  • 21 Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Correlation between endoscopic and angiographic findings in patients with esophageal and isolated gastric varices. Dig Surg 2001; 18 (03) 176-181
    CrossrefPubMedGoogle Scholar
  • 22 Araki T, Hori M, Motosugi U. , et al. Can balloon-occluded retrograde transvenous obliteration be performed for gastric varices without gastrorenal shunts?. J Vasc Interv Radiol 2010; 21 (05) 663-670
    CrossrefPubMedGoogle Scholar
  • 23 Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology 1999; 211 (02) 349-356
    CrossrefPubMedGoogle Scholar
  • 24 Saad WE, Nicholson D, Lippert A. , et al. Balloon-occlusion catheter rupture during balloon-occluded retrograde transvenous obliteration of gastric varices utilizing sodium tetradecyl sulfate: incidence and consequences. Vasc Endovascular Surg 2012; 46 (08) 664-670
    CrossrefPubMedGoogle Scholar
  • 25 Hashizume M, Kitano S, Yamaga H, Sugimachi K. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet 1988; 2 (8606): 340-341
    PubMedGoogle Scholar
  • 26 Ninoi T, Nishida N, Kaminou T. , et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am J Roentgenol 2005; 184 (04) 1340-1346
    CrossrefPubMedGoogle Scholar
  • 27 Gwon DI, Ko GY, Yoon HK. , et al. Gastric varices and hepatic encephalopathy: treatment with vascular plug and gelatin sponge-assisted retrograde transvenous obliteration–a primary report. Radiology 2013; 268 (01) 281-287
    CrossrefPubMedGoogle Scholar
  • 28 Lee EW, Saab S, Gomes AS. , et al. Coil-assisted retrograde transvenous obliteration (CARTO) for the treatment of portal hypertensive variceal bleeding: preliminary results. Clin Transl Gastroenterol 2014; 5: e61
    CrossrefPubMedGoogle Scholar
  • 29 Bellary SV, Isaacs P. Disseminated intravascular coagulation (DIC) after endoscopic injection sclerotherapy with ethanolamine oleate. Endoscopy 1990; 22 (03) 151
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Lee JY, Moon SH, Lee SM. , et al. A case of noncardiogenic pulmonary edema by ethanolamine oleate. Korean J Intern Med 1994; 9 (02) 125-127
    CrossrefPubMedGoogle Scholar
  • 31 Saad WE, Sabri SS. Balloon-occluded retrograde transvenous obliteration (BRTO): technical results and outcomes. Semin Intervent Radiol 2011; 28 (03) 333-338
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Akahoshi T, Tomikawa M, Kamori M. , et al. Impact of balloon-occluded retrograde transvenous obliteration on management of isolated fundal gastric variceal bleeding. Hepatol Res 2012; 42 (04) 385-393
    CrossrefPubMedGoogle Scholar
  • 33 Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery 2001; 129 (04) 414-420
    CrossrefPubMedGoogle Scholar
  • 34 Hiraga N, Aikata H, Takaki S. , et al. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol 2007; 42 (08) 663-672
    CrossrefPubMedGoogle Scholar
  • 35 Hong CH, Kim HJ, Park JH. , et al. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 2009; 24 (03) 372-378
    CrossrefPubMedGoogle Scholar
  • 36 Kim YH, Kim YH, Kim CS, Kang UR, Kim SH, Kim JH. Comparison of balloon-occluded retrograde transvenous obliteration (BRTO) using ethanolamine oleate (EO), BRTO using sodium tetradecyl sulfate (STS) foam and vascular plug-assisted retrograde transvenous obliteration (PARTO). Cardiovasc Intervent Radiol 2016; 39 (06) 840-846
    CrossrefPubMedGoogle Scholar
  • 37 Kitamoto M, Imamura M, Kamada K. , et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR Am J Roentgenol 2002; 178 (05) 1167-1174
    CrossrefPubMedGoogle Scholar
  • 38 Sabri SS, Swee W, Turba UC. , et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol 2011; 22 (03) 309-316 , quiz 316
    CrossrefPubMedGoogle Scholar
  • 39 Park JK, Saab S, Kee ST. , et al. Balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices: review and meta-analysis. Dig Dis Sci 2015; 60 (06) 1543-1553
    CrossrefPubMedGoogle Scholar
  • 40 Itou C, Koizumi J, Hashimoto T. , et al. Balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices: polidocanol foam versus liquid ethanolamine oleate. AJR Am J Roentgenol 2015; 205 (03) 659-666
    CrossrefPubMedGoogle Scholar
  • 41 Mukund A, Rajesh S, Arora A, Patidar Y, Jain D, Sarin SK. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience. J Vasc Interv Radiol 2012; 23 (09) 1200-1206
    CrossrefPubMedGoogle Scholar
  • 42 Kumamoto M, Toyonaga A, Inoue H. , et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome. J Gastroenterol Hepatol 2010; 25 (06) 1129-1135
    CrossrefPubMedGoogle Scholar
  • 43 Akahane T, Iwasaki T, Kobayashi N. , et al. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol 1997; 92 (06) 1026-1030
    PubMedGoogle Scholar
  • 44 Cho SK, Shin SW, Yoo EY. , et al. The short-term effects of balloon-occluded retrograde transvenous obliteration, for treating gastric variceal bleeding, on portal hypertensive changes: a CT evaluation. Korean J Radiol 2007; 8 (06) 520-530
    CrossrefPubMedGoogle Scholar
  • 45 Kobayakawa M, Kokubu S, Hirota S. , et al. Short-term safety and efficacy of balloon-occluded retrograde transvenous obliteration using ethanolamine oleate: results of a prospective, multicenter, single-arm trial. J Vasc Interv Radiol 2017; 28 (08) 1108-1115.e2
    CrossrefPubMedGoogle Scholar
  • 46 Shimoda R, Horiuchi K, Hagiwara S. , et al. Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts. Abdom Imaging 2005; 30 (03) 306-313
    CrossrefPubMedGoogle Scholar
  • 47 Watanabe M, Shiozawa K, Ikehara T. , et al. Short-term effects and early complications of balloon-occluded retrograde transvenous obliteration for gastric varices. ISRN Gastroenterol 2012; 2012: 919371
    PubMedGoogle Scholar
  • 48 Chikamori F, Kuniyoshi N, Kawashima T, Takase Y. Gastric varices with gastrorenal shunt: combined therapy using transjugular retrograde obliteration and partial splenic embolization. AJR Am J Roentgenol 2008; 191 (02) 555-559
    CrossrefPubMedGoogle Scholar
  • 49 Saad WE, Wagner CC, Lippert A. , et al. Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Am J Gastroenterol 2013; 108 (10) 1612-1619
    CrossrefPubMedGoogle Scholar
  • 50 Sabri SS, Abi-Jaoudeh N, Swee W. , et al. Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration. J Vasc Interv Radiol 2014; 25 (03) 355-361
    CrossrefPubMedGoogle Scholar
  • 51 Wang YB, Zhang JY, Gong JP, Zhang F, Zhao Y. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: A meta-analysis. J Gastroenterol Hepatol 2016; 31 (04) 727-733
    CrossrefPubMedGoogle Scholar
  • 52 Lee SJ, Kim SU, Kim MD. , et al. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis. J Gastroenterol Hepatol 2017; 32 (08) 1487-1494
    CrossrefPubMedGoogle Scholar